Pages that link to "Q73195792"
Jump to navigation
Jump to search
The following pages link to Degradation of alpha-synuclein by proteasome (Q73195792):
Displaying 50 items.
- Computational systems analysis of dopamine metabolism (Q21144295) (← links)
- Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase (Q22254584) (← links)
- Correlation between the biochemical pathways altered by mutated Parkinson-related genes and chronic exposure to manganese (Q23914777) (← links)
- The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction (Q24292709) (← links)
- The role of oxidative stress in Parkinson's disease (Q24307946) (← links)
- Upregulation of alpha-synuclein by lipopolysaccharide and interleukin-1 in human macrophages (Q24314013) (← links)
- The synucleins (Q24551013) (← links)
- Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153 (Q24633965) (← links)
- Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection (Q24650675) (← links)
- Cross Talk of Proteostasis and Mitostasis in Cellular Homeodynamics, Ageing, and Disease (Q26765684) (← links)
- Genetically engineered mouse models of Parkinson's disease (Q26852964) (← links)
- Protein degradation pathways in Parkinson's disease: curse or blessing (Q27026029) (← links)
- β-Amyloid triggers ALS-associated TDP-43 pathology in AD models (Q28580544) (← links)
- Pale body-like inclusion formation and neurodegeneration following depletion of 26S proteasomes in mouse brain neurones are independent of α-synuclein (Q28585769) (← links)
- Nigrostriatal neuronal death following chronic dichlorvos exposure: crosstalk between mitochondrial impairments, α synuclein aggregation, oxidative damage and behavioral changes (Q30497542) (← links)
- Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species (Q33360061) (← links)
- PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease (Q33412371) (← links)
- 17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy (Q33525555) (← links)
- In vivo imaging of alpha-synuclein in mouse cortex demonstrates stable expression and differential subcellular compartment mobility (Q33582289) (← links)
- Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia (Q33708946) (← links)
- Studying protein degradation pathways in vivo using a cranial window-based approach (Q33780808) (← links)
- Lysosomal degradation of alpha-synuclein in vivo. (Q33810012) (← links)
- Ubiquitin proteasome system in Parkinson's disease: a keeper or a witness? (Q33828400) (← links)
- Reversing neurodegeneration: a promise unfolds (Q33897927) (← links)
- The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution (Q33980214) (← links)
- Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases (Q34142252) (← links)
- Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategies (Q34152646) (← links)
- The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility (Q34157005) (← links)
- Attenuation of dopamine transporter activity by alpha-synuclein (Q34187960) (← links)
- Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy (Q34238665) (← links)
- Failure of the ubiquitin-proteasome system in Parkinson's disease (Q34325371) (← links)
- Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease? (Q34340531) (← links)
- Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology. (Q34358218) (← links)
- Lewy bodies (Q34478663) (← links)
- Protein aggregates and dementia: is there a common toxicity? (Q34498308) (← links)
- p62/SQSTM1-dependent autophagy of Lewy body-like α-synuclein inclusions (Q34541317) (← links)
- Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation (Q34555995) (← links)
- Parkinson's disease: one biochemical pathway to fit all genes? (Q34688339) (← links)
- Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies (Q34763209) (← links)
- MPTP: insights into parkinsonian neurodegeneration (Q34802076) (← links)
- Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation (Q35085788) (← links)
- Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration (Q35145866) (← links)
- Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies (Q35152946) (← links)
- Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations (Q35165422) (← links)
- Genes and parkinsonism (Q35172294) (← links)
- Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway (Q35344983) (← links)
- Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease. (Q35510197) (← links)
- Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses (Q35550995) (← links)
- The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. (Q35558459) (← links)
- Caught in the act: alpha-synuclein is the culprit in Parkinson's disease (Q35594818) (← links)